Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin (MyoPac)

This study has been terminated.
(Study was stopped due because recrutation.was much slower as anticipated.)
Sponsor:
Information provided by (Responsible Party):
Claudia Lorenz-Schlüter, University of Magdeburg
ClinicalTrials.gov Identifier:
NCT00691912
First received: June 4, 2008
Last updated: September 1, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)